- Home
- NXTC vs FTCI Comparison
NXTC vs FTCI Comparison
Compare NXTC & FTCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXTC
- FTCI
- Stock Information
- Founded
- NXTC 2015
- FTCI 2017
- Country
- NXTC United States
- FTCI United States
- Employees
- NXTC N/A
- FTCI N/A
- Industry
- NXTC Biotechnology: Pharmaceutical Preparations
- FTCI Semiconductors
- Sector
- NXTC Health Care
- FTCI Technology
- Exchange
- NXTC Nasdaq
- FTCI Nasdaq
- Market Cap
- NXTC 40.3M
- FTCI 41.8M
- IPO Year
- NXTC 2019
- FTCI 2021
- Fundamental
- Price
- NXTC $1.42
- FTCI $0.21
- Analyst Decision
- NXTC Strong Buy
- FTCI Buy
- Analyst Count
- NXTC 2
- FTCI 7
- Target Price
- NXTC $6.00
- FTCI $1.11
- AVG Volume (30 Days)
- NXTC 23.4K
- FTCI 1.2M
- Earning Date
- NXTC 10-31-2024
- FTCI 08-08-2024
- Dividend Yield
- NXTC N/A
- FTCI N/A
- EPS Growth
- NXTC N/A
- FTCI N/A
- EPS
- NXTC N/A
- FTCI N/A
- Revenue
- NXTC N/A
- FTCI $77,766,000.00
- Revenue This Year
- NXTC N/A
- FTCI N/A
- Revenue Next Year
- NXTC N/A
- FTCI $137.56
- P/E Ratio
- NXTC N/A
- FTCI N/A
- Revenue Growth
- NXTC N/A
- FTCI N/A
- 52 Week Low
- NXTC $0.98
- FTCI $0.18
- 52 Week High
- NXTC $2.57
- FTCI $1.76
- Technical
- Relative Strength Index (RSI)
- NXTC 34.28
- FTCI 34.06
- Support Level
- NXTC $1.41
- FTCI $0.24
- Resistance Level
- NXTC $1.65
- FTCI $0.23
- Average True Range (ATR)
- NXTC 0.09
- FTCI 0.03
- MACD
- NXTC -0.02
- FTCI 0.00
- Stochastic Oscillator
- NXTC 14.81
- FTCI 2.74
About NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases, and NC181, for Alzheimer's disease.
About FTCI FTC Solar Inc.
FTC Solar Inc is a provider of solar tracker systems, supported by proprietary software and value-added engineering services. The company's Solar tracker systems move solar panels throughout the day to maintain an optimal orientation relative to the sun, thereby increasing the amount of solar energy produced at a solar installation. It focuses on providing differentiated products, software, and services that maximize energy generation. The company has launched a new mounting solution to support the installation and use of U.S. manufactured thin-film modules by project owners. The only segment the company is engaged in is the Manufacturing and Servicing of Solar tracker systems.